nutrients-logo

Journal Browser

Journal Browser

The Effect of Lipoprotein Metabolism on Diabetes and Liver Disease

A special issue of Nutrients (ISSN 2072-6643). This special issue belongs to the section "Lipids".

Deadline for manuscript submissions: closed (20 October 2023) | Viewed by 169

Special Issue Editor


E-Mail Website
Guest Editor
Department of Endocrinology and Metabolism, Faculty of Medicine, Kagawa University, 1750-1 Ikenobe, Miki-cho 761-0793, Kagawa, Japan
Interests: endocrine; diabetes mellitus; HDL; endocrinology; diabetes mellitus

Special Issue Information

Dear Colleagues,

It has long been known that there is a close relationship between abnormal glucose metabolism and liver disease. Dyslipidemia is closely related to type 2 diabetes, NASH/NAFLD, and insulin resistance, in which the former three find a common pathophysiological basis. Ectopic steatosis of the liver and pancreas induces insulin resistance and contributes to the onset of type 2 diabetes, while non-alcoholic fatty liver (NAFL) can progress to NASH. What is the mechanism by which insulin resistance develops from fat accumulation in the liver and the pancreas against a backdrop of overnutrition and obesity? This mechanism is also being researched. Furthermore, various treatments for improving ectopic fat deposition in the liver and pancreas have been reported. Consequently, this Special Issue, “The Effect of Lipoprotein Metabolism on Diabetes and Liver Disease”, aims to gather scientific evidence for the effects of dyslipidemia on diabetes and liver disease and how these effects contribute to pathogenesis.

Prof. Dr. Koji Murao
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Nutrients is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • dyslipidemia
  • diabetes
  • NASH/NAFLD
  • obesity
  • lipoprotein metabolism

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop